Stivarga (regorafenib tablets - Bayer) — Cigna
Central Nervous System Tumors (Glioblastoma or H3-mutated high-grade glioma)
Initial criteria
- Patient age ≥ 18 years
- Patient has recurrent or progressive disease
- Patient has glioblastoma OR H3-mutated high-grade glioma
Approval duration
1 year